Activin-A has been shown to be particularly important in melanoma, where it can affect metastatic potential through evasion of the immune system [165], and one study has shown that prolactin may be a possible early predictive factor in lung cancer patients with metastases [166]. This evidence concerns the gene PRL and melanoma.